Centerra Gold Inc.:企業の戦略・SWOT・財務情報

◆英語タイトル:Centerra Gold Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4253
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:金属・鉱業
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Centerra Gold Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Centerra Gold Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Centerra Gold Inc. (Centerra) is a gold mining company that carries out exploration, operation, development and acquisition of mining properties in Asia, North America and other international markets. It owns and operates two gold producing mines: the Kumtor mine in the southern Tien Shan metallogenic belt in the Kyrgyz Republic and the Boroo mine in Mongolia. The company also owns a 100% interest in Gatsuurt project, presently a development project located in Mongolia. In addition, the company owns various exploration projects such as Oksut in Turkey; ATO in Mongolia and UlaanBulag in Mongolia; and also other exploration projects located in Canada and Turkey. Centerra is headquartered in Toronto, Ontario, Canada.

Scope

- Detailed information on Centerra Gold Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Centerra Gold Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Centerra Gold Inc. including a breakdown and examination of key business segments
- Intelligence on Centerra Gold Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Centerra Gold Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Centerra Gold Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Centerra Gold Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Centerra Gold Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Centerra Gold Inc.: Company Overview 9
Centerra Gold Inc.: Overview and Key Facts 9
Centerra Gold Inc.: Overview 9
Centerra Gold Inc.: Key Facts 9
Centerra Gold Inc.: Key Employees 11
Centerra Gold Inc.: Key Employee Biographies 12
Centerra Gold Inc.: Major Products and Services 14
Centerra Gold Inc.: Company History 15
Centerra Gold Inc.: Management Statement 17
Centerra Gold Inc.: Locations and Subsidiaries 20
Centerra Gold Inc.: Key Competitors 21
Centerra Gold Inc.: Company Analysis 22
Centerra Gold Inc.: Business Description 22
Centerra Gold Inc.: SWOT Analysis 23
Centerra Gold Inc.: SWOT Overview 23
Centerra Gold Inc.: Strengths 23
Centerra Gold Inc.: Weaknesses 24
Centerra Gold Inc.: Opportunities 24
Centerra Gold Inc.: Threats 25
Centerra Gold Inc.: Corporate Financial Deals Activity 26
Centerra Gold Inc.: Financial Deals Overview 26
Centerra Gold Inc.: Targets and Partners 28
Centerra Gold Inc.: Top Deals 2014 – 2018YTD* 29
Centerra Gold Inc.: Advisors 30
Centerra Gold Inc.: Top Legal Advisors 30
Centerra Gold Inc.: Top Financial Advisors 30
Centerra Gold Inc.: Mergers and Acquisitions 31
Centerra Gold Inc.: Corporate Venturing 32
Centerra Gold Inc.: Partnership 33
Centerra Gold Inc.: Divestments 34
Centerra Gold Inc.: Recent Developments 35
Centerra Gold Inc.: News and Events Summary 35
Centerra Gold Inc.: Corporate Governance 38
Centerra Gold Inc.: Financial Deals 38
Centerra Gold Inc.: Financial Performance 39
Centerra Gold Inc.: Strategy and Operations 40
Appendix 42
Contact Us 42
Methodology 42
About MarketLine 43

List of Tables
Table 1: Centerra Gold Inc.: Key Facts
Table 2: Centerra Gold Inc.: Key Employees
Table 3: Centerra Gold Inc.: Locations and Subsidiaries
Table 4: Centerra Gold Inc.: Key Competitors
Table 5: Centerra Gold Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Centerra Gold Inc.: M&A Activity by Geography (TTM*)
Table 7: Centerra Gold Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Centerra Gold Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Centerra Gold Inc.: Targets and Partners
Table 10: Centerra Gold Inc.: Top Deals 2014 - 2018YTD*
Table 11: Centerra Gold Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Centerra Gold Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Centerra Gold Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Centerra Gold Inc.: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Centerra Gold Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Centerra Gold Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Centerra Gold Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 18: Centerra Gold Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 19: Centerra Gold Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 20: Centerra Gold Inc.: News and Events Summary
Table 21: Centerra Gold Inc.: Corporate Governance
Table 22: Centerra Gold Inc.: Financial Deals
Table 23: Centerra Gold Inc.: Financial Performance
Table 24: Centerra Gold Inc.: Strategy and Operations

List of Figures
Figure 1: Centerra Gold Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Centerra Gold Inc.: M&A Activity by Geography (TTM*)
Figure 3: Centerra Gold Inc.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Centerra Gold Inc.: M&A Average Deal Size - Value (US$m)
Figure 5: Centerra Gold Inc.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Centerra Gold Inc.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Centerra Gold Inc.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Centerra Gold Inc.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Centerra Gold Inc.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 10: Centerra Gold Inc.: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 11: Centerra Gold Inc.: Divestments Volume and Value Trend (2014 - YTD*2018)

★海外企業調査レポート[Centerra Gold Inc.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • OSE Immunotherapeutics (OSE):企業の財務・戦略的SWOT分析
    Summary OSE Immunotherapeutics (OSE), formerly OSE Pharma SA, is a biotechnology company that discovers and develops immunotherapy products against invasive and metastatic late-stage cancers. The company’s memopi technology is employed in studying the development of treatments for ovarian, colon and …
  • Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Carnarvon Petroleum Ltd Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive inform …
  • Promedior Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Promedior Inc (Promedior) is a clinical-stage biotechnology company that develops medicines for the treatment of fibrotic disorders. The company’s pipeline products include PRM-151 and PRM-167. PRM-151 is used in the treatment of rare systemic fibrotic diseases such as myelofibrosis and idio …
  • Transcatheter Technologies GmbH-医療機器分野:企業M&A・提携分析
    Summary Transcatheter Technologies GmbH (Transcatheter) is a medical equipment company that develops aortic valve implantation system. The company develops technologies for self-expanding valve prostheses and endovascular stents through inner catheters. It develops aortic valve implantation system f …
  • IPCA Laboratories Ltd (IPCALAB):企業の財務・戦略的SWOT分析
    Summary IPCA Laboratories Ltd (IPCA) is a manufacturer and supplier of active pharmaceutical ingredients (API’s), generics and branded formulations. It is one of India's largest formulation exporters and is specialized in anti-malarial and anti-bacterials therapeutic segments. The company offers API …
  • PT Pembangkitan Jawa-Bali:企業の戦略的SWOT分析
    PT Pembangkitan Jawa-Bali - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Societe BIC (BB):企業の財務・戦略的SWOT分析
    Societe BIC (BB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Zhejiang Yatai Pharmaceutical Co Ltd (002370):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Yatai Pharmaceutical Co Ltd (Yatai Pharmaceutical), formerly Asia-Pacific Pharmaceutical Factory, is a pharmaceutical company. The company develops, researches, and manufactures pharmaceuticals including penicillin, cephalosporins and hormones. It offers transdermal controlled-relea …
  • Apexigen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Apexigen Inc (Apexigen) is a clinical-stage biopharmaceutical company that discovers and develops antibody-based drugs for the treatment of cancer. The company’s lead immune oncology program APX005M, is a humanized monoclonal antibody that stimulates cancer specific T-cell responses. It also …
  • Nautilus Minerals Inc:企業の戦略・SWOT・財務情報
    Nautilus Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary Nautilus Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Daily Mail & General Trust plc (DMGT):企業の財務・戦略的SWOT分析
    Daily Mail & General Trust plc (DMGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • CIRCOR International, Inc. (CIR)-石油・ガス分野:企業M&A・提携分析
    Summary CIRCOR International, Inc. (CIRCOR) is an industrial equipment company that designs, manufactures, and markets flow control solutions and engineered products and sub-systems. Its product offerings include integrated flow control solutions, high pressure pneumatic systems, valves, actuation, …
  • GNI Group Ltd (2160):企業の財務・戦略的SWOT分析
    Summary GNI Group Ltd (GNI) is a healthcare service provider that researches, develops, manufactures and markets pharmaceutical drugs. The company’s business operations consist of drug discovery activities such as drug discovery research, drug discovery infrastructure, fundamental drug discovery and …
  • Forum Energy Technologies Inc:企業の戦略・SWOT・財務情報
    Forum Energy Technologies Inc - Strategy, SWOT and Corporate Finance Report Summary Forum Energy Technologies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Turquoise Hill Resources Ltd:企業の戦略・SWOT・財務情報
    Turquoise Hill Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Turquoise Hill Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Next Fifteen Communications Group plc:企業のM&A・事業提携・投資動向
    Next Fifteen Communications Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Next Fifteen Communications Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed report …
  • Celldex Therapeutics, Inc.:企業の戦略・SWOT・財務分析
    Celldex Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Celldex Therapeutics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • DiaSorin SpA (DIA):企業の財務・戦略的SWOT分析
    DiaSorin SpA (DIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Crescita Therapeutics Inc (CTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Crescita Therapeutics Inc (Crescita Therapeutics) is a commercial dermatology company that offers prescription drug products for the treatment and care of skin conditions and diseases and their symptoms. The company’s products comprise Pliaglis, Alyria, Laboratoire Dr Renaud, Pro-Derm, Premi …
  • Spectris plc:企業の戦略・SWOT・財務情報
    Spectris plc - Strategy, SWOT and Corporate Finance Report Summary Spectris plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆